alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

114TH CONGRESS 

1ST SESSION H. R. 2309 

To amend the Equal Credit Opportunity Act to prohibit discrimination on 

account of sexual orientation or gender identity when extending credit. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 13, 2015 

Mr. ISRAEL (for himself, Ms. JUDY CHU of California, Ms. HAHN, Mr. BLUMENAUER, Mr. SWALWELL of California, Ms. SCHAKOWSKY, Ms. TSONGAS, Mr. ELLISON, Ms. WASSERMAN SCHULTZ, Mr. PETERS, Mr. SEAN

PATRICK MALONEY of New York, Mr. GRIJALVA, Ms. CLARKE of New 

York, Mrs. DAVIS of California, Mrs. CAROLYN B. MALONEY of New 

York, Mr. DELANEY, Mr. POLIS, Mr. FATTAH, Mr. CICILLINE, Mr. 

SHERMAN, Mr. CONNOLLY, Ms. SPEIER, Ms. NORTON, Mr. CA ́RDENAS, 

Mr. RANGEL, Ms. DELBENE, Mrs. WATSON COLEMAN, Mr. TED LIEU

of California, Ms. LEE, Mr. FARR, Mr. LANGEVIN, Ms. PINGREE, Ms. 

WILSON of Florida, Mr. HIMES, Mr. MCDERMOTT, Ms. ADAMS, Mr. 

POCAN, Mr. NADLER, Mr. LOWENTHAL, Mr. CROWLEY, and Ms. ROYBAL-ALLARD) introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To amend the Equal Credit Opportunity Act to prohibit 

discrimination on account of sexual orientation or gender 

identity when extending credit. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 2309 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Freedom from Dis3 crimination in Credit Act of 2015’’. 

4 SEC. 2. PROHIBITION AGAINST DISCRIMINATION ON AC5 COUNT OF SEXUAL ORIENTATION OR GEN6 DER IDENTITY. 

7 Subsection (a)(1) of section 701 of the Equal Credit 

8 Opportunity Act (15 U.S.C. 1691) is amended, by striking 

9 ‘‘on the basis of race, color, religion, national origin, sex 

10 or marital status,’’ and inserting ‘‘on the basis of actual 

11 or perceived race, color, religion, national origin, sex, sex12 ual orientation, gender identity, or marital status,’’. 

13 SEC. 3. DEFINITIONS. 

14 Section 702 of the Equal Credit Opportunity Act (15 

15 U.S.C. 1691a) is amended— 

16 (1) by redesignating subsections (f) and (g) as 

17 subsections (g) and (i), respectively; 

18 (2) by inserting after subsection (e) the fol19 lowing new subsections: 

20 ‘‘(f) The term ‘gender identity’ means the gender-re21 lated identity, appearance, or mannerisms or other gen22 der-related characteristics of an individual, with or with23 out regard to the individual’s designated sex at birth.’’; 

24 and 

25 (3) by inserting after subsection (g), as so re26 designated, the following: 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•HR 2309 IH

1 ‘‘(h) The term ‘sexual orientation’ means homosex2 uality, heterosexuality, or bisexuality.’’. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
# C_2021209EN.01000201.xml

| 2.6.2021 | EN | Official Journal of the European Union | C 209/2 |
| --- | --- | --- | --- |

2.6.2021

EN

Official Journal of the European Union

C 209/2

---

Non-opposition to a notified concentration

(Case M.10228 — Advent/Mondial Relay)

(Text with EEA relevance)

(2021/C 209/02)

On 28 May 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10228. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10228. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Listen

# Jack Brewer

## CSSBMB Commissioner

Commissioner Brewer possesses a unique combination of expertise in the fields of global economic development, sports and finance through his roles as a successful entrepreneur, executive producer, news contributor and humanitarian. He currently serves as CEO & Portfolio Manager of The Brewer Group, Inc., White House Appointee on the US Commission for the Social Status of Black Men & Boys, Chair at the America First Policy Institute’s Center for Opportunity Now, and the Founder and Executive Director of The Jack Brewer Foundation (JBF Worldwide). For over a decade, Brewer has been continuously originating, structuring and facilitating comprehensive strategic investments and partnerships, while leading numerous multinational companies to become leading advocates at the forefront of some of the world's most pressing issues.

-  Our Mission 
-  Commissioners 
-  Offices and Staff 
-  Careers 
-  Acquisition Opportunities 
-  Rankin Memorial Library 
-  FAQs
#### O’CONNELL, Respondent, v. CLARK et al., Appellants.

(Supreme Court, Appellate Division, Second Department.

October 27, 1896.)

Action by James O’Connell against John Clark and another.

No opinion. Motion for reargument denied, without costs. See 39 N. Y. Supp. 454.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<CIK> 0001018748
<NAME> VIRGINIA GOLF COUNTRY CLUB, INC
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<CASH>                                          42,184
<SECURITIES>                                         0
<RECEIVABLES>                                  304,430
<ALLOWANCES>                                    41,444
<INVENTORY>                                     82,089
<CURRENT-ASSETS>                               307,593
<PP&E>                                       9,444,330
<DEPRECIATION>                                 722,199
<TOTAL-ASSETS>                               9,425,121
<CURRENT-LIABILITIES>                          200,392
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                   9,119,543
<TOTAL-LIABILITY-AND-EQUITY>                 9,425,121
<SALES>                                        614,907
<TOTAL-REVENUES>                             3,346,140
<CGS>                                          266,588
<TOTAL-COSTS>                                2,658,383
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                11,053
<INTEREST-EXPENSE>                              34,024
<INCOME-PRETAX>                                653,733
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            653,733
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   653,733
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Exhibit 23.3

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation
by reference in the Registration Statements on Forms S-3 (Nos. 333-182703, 333-169132, 333-148060, 333-107137, 333-122114, 333-117717, 333-125565, 333-140110, 333-152591, 333-132611, 333-111894, 333-105509, 333-165958, 333-165960, 333-178592,
333-178832, 333-96813, 333-46967 and 333-91957) and Forms S-8 (Nos. 333-182704, 333-152284, 333-138598, 333-174392, 333-167365 and 333-93435) of Apricus Biosciences, Inc. of our report dated March 18, 2013, except for the matter described in
the penultimate paragraph of Managements Report on Internal Control over Financial Reporting, as to which the date is September 30, 2013, relating to the financial statements and the effectiveness of internal control over financial reporting,
which appears in this Form 10-K/A (Amendment No. 1).



|                              
|------------------------------
|/s/ PricewaterhouseCoopers LLP
|                              
|San Diego, CA                 
|September 30, 2013
EX-10.15





 Exhibit 10.15 

SPOUSAL CONSENT 
 I, Shen
Xia (ID No.: ***************), is the legally spouse of Luo Jian (ID No.: ***************). I hereby unconditionally and irrevocably consent to the execution of the following documents (collectively the “Transaction Documents”,
including, for the avoidance of doubt, other relevant documents executed for the purpose of engaging in the transactions contemplated by the Transaction Documents, as the same may be amended from time to time) by Luo Jian and to the disposal of the
equity interest in Beijing Xingengyuan Science and Technology Co., Ltd. (the “Company”) registered in the name of Luo Jian in accordance with the following Transaction Documents: 

1. Exclusive Option Agreement among Luo Jian , the Company and Beijing Spark Education and Technology Co., Ltd. (the “WFOE”) on
July 24, 2020 ; 
 2. Equity Pledge Agreement among Luo Jian , the Company and WFOE on July 24, 2020 ; 

3. Power of Attorney among Luo Jian , the Company and the WFOE on July 24, 2020. 

I undertake not to make any claims in respect of the equity interest held by Luo Jian in the Company. I further confirm that the performance
by Luo Jian of the Transaction Documents and further amendment to or termination of the Transaction Documents do not need my further authorization or consent. I undertake to execute all necessary documents and take all necessary actions to ensure
that the Transaction Documents shall be duly performed. 
 I agree and undertake that if I acquire any equity interest in the Company held
by Luo Jian for whatever reason, I shall be bound by the Transaction Documents and comply with my obligations as a shareholder of the Company thereunder, and for this purpose, upon request by the WFOE, I shall sign a series of written documents
substantially in the same form and substance as the Transaction Documents. 
 This Consent Letter shall become effective from the date of
signing. 
  

	
	Signature: /s/ Shen Xia
                                    
	
	Name: Shen Xia
	
	Date: July 24, 2020


 SPOUSAL CONSENT LETTER
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

349 

CA 11-01572 

PRESENT: CENTRA, J.P., FAHEY, LINDLEY, SCONIERS, AND MARTOCHE, JJ. 

 

M&T REAL ESTATE TRUST, SUCCESSOR BY MERGER TO 

M&T REAL ESTATE, INC., PLAINTIFF-RESPONDENT, 

V ORDER

JAMES J. DOYLE, II, AND JIM DOYLE FORD, INC., 

DEFENDANTS-APPELLANTS. 

(APPEAL NO. 1.) 

 

GROSS, SHUMAN, BRIZDLE & GILFILLAN, P.C., BUFFALO (JOHN K. ROTTARIS OF

COUNSEL), FOR DEFENDANTS-APPELLANTS. 

JAECKLE FLEISCHMANN & MUGEL, LLP, BUFFALO (HOWARD S. ROSENHOCH OF

COUNSEL), FOR PLAINTIFF-RESPONDENT. 

 

Appeal from an order of the Supreme Court, Erie County (Michael

L. D’Amico, A.J.), entered June 29, 2011 in a proceeding pursuant to

RPAPL article 13. The order, among other things, granted plaintiff’s

motion for leave to enter a deficiency judgment against defendants. 

It is hereby ORDERED that said appeal is unanimously dismissed

without costs (see Hughes v Nussbaumer, Clarke & Velzy, 140 AD2d 988;

Chase Manhattan Bank, N.A. v Roberts & Roberts, 63 AD2d 566, 567; see

also CPLR 5501 [a] [1]).

Entered: March 23, 2012 Frances E. Cafarell

Clerk of the Court
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information derived from Kiddie Academy
International, Inc.'s unaudited financial statements for the sixteen weeks ended
January 19, 1997, and is qualified in its entirety by reference to such
financial statements and the notes thereto.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   4-MOS
<FISCAL-YEAR-END>                          SEP-28-1997
<PERIOD-END>                               JAN-19-1997
<CASH>                                             639
<SECURITIES>                                         0
<RECEIVABLES>                                      128
<ALLOWANCES>                                         0
<INVENTORY>                                         82
<CURRENT-ASSETS>                                 1,869
<PP&E>                                           1,024
<DEPRECIATION>                                     342
<TOTAL-ASSETS>                                   2,945
<CURRENT-LIABILITIES>                            2,120
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            20
<OTHER-SE>                                         259
<TOTAL-LIABILITY-AND-EQUITY>                     2,945
<SALES>                                          2,273
<TOTAL-REVENUES>                                 2,273
<CGS>                                            2,786
<TOTAL-COSTS>                                    2,786
<OTHER-EXPENSES>                                   142
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   8
<INCOME-PRETAX>                                  (363)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (363)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (363)
<EPS-PRIMARY>                                   (0.18)
<EPS-DILUTED>                                   (0.18)
        

</TABLE>
@nitr! 5tsftn @ourt of frlrrul @hims

717 MADISON PLACE. NW

WASHINGTON, DC 20439

OFFICE OF THE CLERK OF COURT

(202) 357-6406

January 9,2017

The Honorable Joseph R. Biden, Jr.

President of the United States Senate

The Capitol

Room 3-212

Washington, DC 20510

Dear Mr. President:

Enclosed are two copies of the Annual Report of the United States Court of Federal

Claims for the year ended September 30,2016 as required by Section 791(c), Title 28, United

States Code.

Very truly yours,

Qrz@

Lisa L. Reyes

Acting Clerk of Court

Enclosures:

l. Report of Vaccine Case Judgments for Pain and Suffering - FYl6

2. Report of Vaccine Case Judgments for Lost Wages - FY16

3. Report of Judgments entered by the U.S. Court of Federal Claims - FYl6
March 5, 2015

JUDGMENT

The Fourteenth Court of Appeals

EX PARTE JOSHUA BAINES, Appellant

NO. 14-15-00050-CR 

________________________________

This cause was heard on the motion of the appellant to withdraw notice of 

appeal. Having considered the motion the Court orders the appeal DISMISSED.

We further order appellant pay all costs expended in the appeal.

We further order the mandate be issued immediately. We further order this 

decision certified below for observance.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0001000897
<NAME>                        Azurel LTD. and Subsidaries
<MULTIPLIER>                                   1
<CURRENCY>                                     u.s.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   SEP-30-1997
<EXCHANGE-RATE>                                1
<CASH>                                         694,697
<SECURITIES>                                   0
<RECEIVABLES>                                  2,049,589
<ALLOWANCES>                                   50,000
<INVENTORY>                                    1,091,213
<CURRENT-ASSETS>                               4,870,249
<PP&E>                                         1,582,161
<DEPRECIATION>                                 147,046
<TOTAL-ASSETS>                                 9,384,023
<CURRENT-LIABILITIES>                          3,516,625
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       5,390
<OTHER-SE>                                     7,376,283
<TOTAL-LIABILITY-AND-EQUITY>                   4,616,414
<SALES>                                        3,060,483
<TOTAL-REVENUES>                               3,060,483
<CGS>                                          2,204,093
<TOTAL-COSTS>                                  2,204,093
<OTHER-EXPENSES>                               644,316
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             91,138
<INCOME-PRETAX>                                136,571
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   136,571
<EPS-PRIMARY>                                  0.03
<EPS-DILUTED>                                  0
        




</TABLE>
**Exhibit 23.1**

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Nos.333-64495, 333-149882 and 333-125863 on Form S-8 of Altair Nanotechnologies Inc. and subsidiaries of our report dated April 1, 2013 on the consolidated balance sheet of Altair Nanotechnologies Inc. and subsidiaries as of December 31, 2012 and the consolidated statements of operations and comprehensive loss, stockholders’(deficit) equity, and cash flows for the year then ended, appearing in this Annual Report on Form 10-K

 

 

/s/ Crowe Horwath LLP

 

Crowe Horwath LLP

Sacramento, California

November 15, 2016
# C_2021024EN.01000701.xml

| 22.1.2021 | EN | Official Journal of the European Union | C 24/7 |
| --- | --- | --- | --- |

22.1.2021

EN

Official Journal of the European Union

C 24/7

---

Non-opposition to a notified concentration

(Case M.9911 — Voith/PCSH/TSA)

(Text with EEA relevance)

(2021/C 24/03)

On 19 November 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in German language and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9911. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9911. EUR-Lex is the on-line access to the European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Exhibit 10.4


 


FORM OF WAIVER


 


In
consideration for the benefits I will receive as a result of my employer’s
participation in the United States Department of the Treasury’s TARP Capital
Purchase Program, I hereby voluntarily waive any claim against the United
States or my employer for any changes to my compensation or benefits that are
required to comply with the regulation issued by the Department of the Treasury
as published in the Federal Register on October 20, 2008.


 


I acknowledge
that this regulation may require modification of the compensation, bonus,
incentive and other benefit plans, arrangements, policies and agreements
(including so-called “golden parachute” agreements) that I have with my
employer or in which I participate as they relate to the period the United
States holds any equity or debt securities of my employer acquired through the
TARP Capital Purchase Program.


 


This waiver
includes all claims I may have under the laws of the United States or any state
related to the requirements imposed by the aforementioned regulation, including
without limitation a claim for any compensation or other payments I would
otherwise receive, any challenge to the process by which this regulation was
adopted and any tort or constitutional claim about the effect of these
regulations on my employment relationship.


 




	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [Name]

  
	
   

  	
   

  	
  December 12,
  2008
Listen

# Advisory Committees News

South Carolina Advisory Committee Releases Report on Civil Asset Forfeiture
December 5, 2022

U.S. Commission on Civil Rights Releases Report: Contemporary Civil Rights Challenges: A View from the State Advisory Committees
November 17, 2022

Georgia Advisory Committee Releases Report on Civil Asset Forfeiture and its Impact on Communities of Color in Georgia
November 15, 2022

Tennessee Advisory Committee Releases Interim Memorandum on Access to Voting in Tennessee
November 15, 2022

U. S. Commission on Civil Rights to Release Report: Contemporary Civil Rights Challenges: A View from the State Advisory Committees
November 7, 2022

The U.S. Commission on Civil Rights Announce the Appointments of Advisory Committee Members for Utah
October 26, 2022

Texas Advisory Committee Releases Interim Memorandum on Mental Health Care in the Juvenile Justice System
October 17, 2022

Maryland Advisory Committee Releases Report on Water Affordability
August 4, 2022

The U.S. Commission on Civil Rights Announce the Appointments of Advisory Committee Members for the U.S. Virgin Islands
July 25, 2022

The U.S. Commission on Civil Rights Announce the Appointments of Advisory Committee Members for the Northern Mariana Islands
July 21, 2022

-    First  
-    Previous  
-   ...  
-  2 
-  3 
-  4 
-   ...  
-   Next  
-   Last  

-  All News 
-  Commission News 
-  Advisory Committees News 
-  Correspondence 
-  Videos 
-  Archives 

## Meetings

### Recent and Upcoming

U.S. Virgin Islands Advisory Committee Community Forum
April 10, 2024

Arizona Advisory Committee Public Web Briefing on Racial and Ethnic Disparities in Pediatric Healthcare - Panel IV
March 26, 2024

VIEW ALL